在怀孕期间对COVID-19疫苗接种的认识和安全性
Pragya Shree1, Vandana Verma2, Neetika Patel1
1A.S.J.S.T.D.S. Medical College, Fatehpur, India.
Journal of obstetrics and gynaecology of India
|May 6, 2024
概括
在怀孕期间接种COVID-19疫苗是安全的,并建议,因为益处超过潜在的风险. 孕产妇接种疫苗有助于保护新生儿免受严重疾病,有助于控制流行病.
科学领域:
- 产科和妇科 产科和妇科
- 疫苗学 疫苗学 疫苗学
- 新生儿健康 新生儿健康
背景情况:
- 对于孕妇来说,COVID-19疫苗是安全的,因为它们不含活体减弱病毒.
- 孕产妇接种疫苗对于保护新生儿至关重要,新生儿容易患上严重的COVID-19疾病.
- 大规模疫苗接种是控制COVID-19大流行的一个关键策略.
研究的目的:
- 调查孕妇COVID-19疫苗接种的疗效,安全性和母婴结局.
- 评估孕妇的态度和与COVID-19疫苗接种相关的副作用.
- 评估COVID-19疫苗接种对怀孕和新生儿健康结果的影响.
主要方法:
- 一项基于医院的横截面研究进行了一年 (2021年11月至2022年10月).
- 从孕妇收集有关COVID-19疫苗接种状态,态度和副作用的数据.
- 对母亲和新生儿结果的分析,包括分娩方法,产前/产后并发症和新生儿健康指标.
主要成果:
- 只有35.24%的孕妇接受了至少一剂COVID-19疫苗;许多人不知道疫苗类型.
- 常见的副作用包括第一剂后发烧和寒,第二剂后疲劳;没有报告过敏反应.
- 虽然观察到一些不良的妊娠结果 (例如,贫血,早产),新生儿的结果通常是有利的,大多数新生儿的APGAR分数很好,尽管有些人需要入院NICU.
结论:
- 现有数据不表明在怀孕期间接种COVID-19疫苗后,不良结果的风险增加.
- 建议在怀孕期间接种疫苗,因为被认为益处超过潜在风险.
- 孕产妇COVID-19疫苗接种在保护母亲和新生儿方面发挥着至关重要的作用.
相关概念视频
Vaccinations
44.4K
Overview
44.4K
Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
276
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
276
Development of Immunocompetence
303
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
303
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K


